AdaptHealth (AHCO) Free Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn | -123.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.56% |
| Dec 31, 2025 | 26.74% |
| Sep 30, 2025 | -40.49% |
| Jun 30, 2025 | 38.01% |
| Mar 31, 2025 | 195.94% |
| Dec 31, 2024 | 194.19% |
| Sep 30, 2024 | 168.75% |
| Jun 30, 2024 | 32.15% |
| Mar 31, 2024 | -136.90% |
| Dec 31, 2023 | -221.17% |
| Sep 30, 2023 | -52.83% |
| Jun 30, 2023 | 457.95% |
| Mar 31, 2023 | 161.59% |
| Dec 31, 2022 | 231.21% |
| Sep 30, 2022 | 327.70% |
| Jun 30, 2022 | -119.23% |
| Mar 31, 2022 | 5,009.39% |
| Dec 31, 2021 | 11.61% |
| Sep 30, 2021 | -513.44% |
| Jun 30, 2021 | 53.64% |
| Mar 31, 2021 | -104.95% |
| Dec 31, 2020 | 660.55% |
| Sep 30, 2020 | 15.28% |
| Jun 30, 2020 | 1,815.39% |
| Mar 31, 2020 | 51.51% |
| Dec 31, 2019 | -93.69% |
| Sep 30, 2019 | 5,541.65% |
| Jun 30, 2019 | 917.73% |
| Mar 31, 2019 | 2,976.00% |